This study with recombinant reconstituted system mimicking the cellular conditions of the native cones documents that photoreceptor ROS-GC1 is modulated by gaseous CO 2 . Mechanistically, CO 2 is sensed by carbonic anhydrase (CAII), generates bicarbonate that, in turn, directly targets the core catalytic domain of ROS-GC1, and activates it to increased synthesis of cyclic GMP. This, then, functions as a second messenger for the cone phototransduction. The study demonstrates that, in contrast to the Ca 2+ -modulated phototransduction, the CO 2 pathway is Ca 2+ -independent, yet is linked with it and synergizes it. It, through R 787 C mutation in the third heptad of the signal helix domain of ROS-GC1, affects cone-rod dystrophy, CORD6. CORD6 is caused firstly by lowered basal and GCAP1-dependent ROS-GC1 activity and secondly, by a shift in Ca 2+ sensitivity of the ROS-GC1/GCAP1 complex that remains active in darkness. Remarkably, the first but not the second defect disappears with bicarbonate thus explaining the basis for CORD6 pathological severity. Because cones, but not rods, express CAII, the excessive synthesis of cyclic GMP would be most acute in cones.
Introduction
ROS-GC1 is one of seven members of the mammalian membrane guanylate cyclase family encoded by a gene localized to human chromosome 17p13.1 [1] [2] [3] . Physiologically, it is integral to visual transduction [4, 5] (reviewed in ref. [6] ), the biochemical process by which rods and cones in the retina convert incoming light into an electrical signal. ROS-GC1 generates cyclic GMP, the second messenger of the signal. It controls all of the cyclic GMP production in cones and about 95% of the cyclic GMP production in the rod [7, 8] , the other 5% being generated by the second ROS-GC member, ROS-GC2 [9] [10] [11] . Turnover of phototransduction and recovery of cyclic GMP levels are critical for positioning the amplitude, bestowing reproducibility, and for adjusting the duration of the photon response [12] [13] [14] [15] . The catalytic activity of ROS-GC1 is inversely tied to the intracellular free Ca 2+ concentration. In darkness, cyclic GMP levels are at their basal levels; the CNG channels are open and the inward current is carried by Na + and Ca 2+ . Efflux of Ca 2+ through a Na + /K + , Ca 2+ exchanger maintains an intracellular [Ca 2+ ] of ~ 250 nM in mouse [16] and ~ 800 nM in salamander outer segments [17] . Light sparks hydrolysis of cyclic GMP and closure of the CNG channels. The influx of Ca 2+ stops, yet extrusion through the exchanger persists, decreasing the intracellular [Ca 2+ ] by as much as an order of magnitude. The Ca 2+ -sensing GCAP subunits of the ROS-GC1 complex kick-start the catalytic activation of ROS-GC1. In rods, GCAP1 is the "first responder"; the continued decline in [Ca 2+ ] i recruits GCAP2, which further stimulates ROS-GC1. As the cyclic GMP concentration recovers, CNG channels reopen to allow a rise in intracellular Ca 2+ , which then returns ROS-GC1 catalytic activity back to its basal level.
The GCAP1-modulated Ca 2+ signal originates at the juxtamembrane domain (JMD), whereupon it undergoes successive processing by the WTAPELL motif in the kinase homology domain [18] and by the signaling helix domain (SHD) before converging on the core catalytic domain (CCD) (Fig. 1 ). An additional mode of modulation is
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Ca 2+ -independent and occurs through bicarbonate, presumably formed from gaseous CO 2 . Bicarbonate raises basal enzymatic activity as well as maximal activity at low [Ca 2+ ] i by binding directly to the CCD.
Several mutations in the ROS-GC1 gene (GUCY2D) are linked with retinal diseases, Leber's congenital amaurosis (LCA) and cone-rod dystrophies (CORDs), marked by the progressive and irreversible loss of vision [20] [21] [22] [23] [24] . Molecular analyses of LCA1 and CORDs reveal a common biochemical theme [25] [26] [27] [28] . The mutations lower basal catalytic activity of the ROS-GC1 and alter the GCAPs signaling pathways [25] [26] [27] [28] . Consequently, the light-dependent fluctuations of cyclic GMP and Ca 2+ concentrations are negatively affected, resulting first in the death of the cone and then of the rod photoreceptors [25] [26] [27] [28] .
The R 787 C (corresponding to human R 838 C) mutation in ROS-GC1 gene leads to familial CORD type 6 (CORD6). R 787 occupies the central position within the third heptad of the signaling helix domain, SHD ( Fig. 1: marked in red) . The mutation shifts Ca 2+ sensitivity to higher concentrations leading to the proposal that photoreceptor degeneration results from defective negative Ca 2+ feedback that raises intracellular cyclic GMP to abnormally high levels in darkness. However, the mutation also reduces basal and maximal enzymatic activity at low Ca 2+ , making it difficult to reconcile the autosomal dominant nature of the disease.
The present study was designed to test (1) the CO 2 /bicarbonate signaling pathway of ROS-GC1, (2) its molecular linkage with the Ca 2+ -modulated GCAP1 phototransduction pathway operating in cone photoreceptors, and (3) how CO 2 affects the functioning of cone photoreceptors afflicted by the CORD6-causing R 787 C mutation in ROS-GC1.
Materials and methods

Reconstituted systems
Two bovine ROS-GC1 mutants were constructed: R 787 C and ΔH3. The conversion of R 787 →C and the deletion of the third heptad (ΔH3; aa 784-790) of the signaling helix domain of ROS-GC1 were performed by polymerase chain reaction (PCR) using the following mutagenic primers: FW, 5′-CCT GAT CCG GGA GTG CAC AGA GGA GCTG-3′, Rev, 5′-CAG CTC CTC TGT GCA CTC CCG GAT CAGG-3′ for the R 787 C mutant and FW, 5′-AGT AAC CTG GAG GAC CTG CTG GAG CTG GAA AAG CAG -3′, Rev, 5′-CTG CTT TTC CAG CTC CAG CAG GTC CTC CAG GTT ACT -3′ for the ΔH3 mutant.
Expression in a heterologous system
COS-7 cells (purchased from ATCC CRL-1651 and maintained in our laboratory) were induced to express ROS-GC1 or its mutants using a calcium-phosphate coprecipitation [29] or Lipofectamine (Thermo Fisher Scientific). Seventy hours after transfection, the cells were harvested and their membranes prepared [30] .
Co-expression of ROS-GC1 and carbonic anhydrase type II (CAII)
Bovine ROS-GC1 and mouse CAII cDNAs were cloned into pBudCE4.1 vector (Thermo Fisher Scientific), respectively, into Not1/Xho1 sites of the EF-1a multiple cloning site and Sal1/Xba1 sites of the CMV multiple cloning site. The construct was verified by sequencing and used for ROS-GC1-CAII co-expression in COS cells.
Immunohistochemistry
The construction of GFP-GCAP1 was described previously [18, 31] . GFP-GCAP1 was expressed together with ROS-GC1 or its R 787 C mutant in COS cells grown on coverslips in chambers in DMEM medium supplemented with 10% fetal bovine serum. Seventy hours after transfection, the cells were fixed in 4% formaldehyde in phosphate-buffered saline (PBS) for 10 min at room temperature. The fixed cells were washed with tris-buffered saline (TBS), blocked in 10% preimmune donkey serum in TBS/0.5% Triton X-100 (TTBS) for 1 h at room temperature, washed with TTBS, Fig. 1 Modular composition of the bovine ROS-GC1 dimer. A 56 amino acid leader sequence (LS) precedes the extracellular domain (ExtD) in the nascent, immature protein. All signaling events occur in the intracellular domain (ICD), which is separated from ExtD by a transmembrane domain (TMD). ICD is composed of the following domains: juxtamembrane (JMD), kinase homology (KHD), signaling helix (SHD), catalytic core (CCD), and C-terminal extension (CTE). GCAP1 binds to the JMD. The SHD is expanded below the dimer to show the sequences of five heptad segments. Heptad 3 is shadowed and the R 787 residue in the center of this heptad is highlighted in red. Highlighted Q and K residues in heptad 4 are also prone to mutations leading to CORD [19] incubated with ROS-GC1 antibody in blocking solution overnight at 4 °C, washed with TTBS and then incubated with AlexaAfluor 647-conjugated secondary antibody for 1 h and washed with TTBS. For GFP, the excitation and emission wavelengths were 475 and 505 nm, respectively; for AlexaFluor647, they were 651 and 667 nm. Images were acquired using an inverted Olympus IX81 microscope/ FV1000 Spectral laser confocal system, and analyzed using Olympus FluoView FV10-ASW software. Digital images were processed using Adobe Photoshop software.
Assay of guanylate cyclase activity
Membrane samples of transfected COS cells were incubated individually without or with varying concentrations of recombinant bovine GCAP1 and/or NaHCO 3 . GCAP1 was purified as described in [18] . The assay mixture (25 µl) consisted of the following (mM): 10 theophylline, 15 phosphocreatine, and 50 Tris-HCl; pH 7.5, and 20 µg creatine kinase (Sigma). In experiments with GCAP1, 1 mM EGTA was added to the reaction mixture; when the bicarbonate effect was tested, neither EGTA nor Ca 2+ was added. The reaction was initiated by addition of the substrate solution 4 mM MgCl 2 and 1 mM GTP (final concentrations) and maintained by incubation at 37 °C for 10 min. In the experiment for [GTP] dependency of guanylate cyclase activity (Fig. 3c) , the GTP concentrations varied from 0 to 1.5 mM and the MgCl 2 concentration was constant, 4 mM. The reaction was terminated by the addition of 225 µl of 50 mM sodium acetate buffer, pH 6.2, followed by heating on a boiling water bath for 3 min. The amount of cyclic GMP formed was determined by radioimmunoassay [32] . All assays were done in triplicate and, except where stated otherwise, were performed three times. Guanylate cyclase activity is presented as average ± SD of three experiments done in triplicate.
To correlate the catalytic changes brought about by the mutations, the activities of the mutants were compared with wild-type recombinant ROS-GC1 through Michaelis plots for the ligand used by fitting the data with the Hill equation, v = V max (S)/K M + Sn. V max is the activity; S is the concentration of the ligand; K M is the substrate concentration at which half-maximal velocity is achieved, and n is the Hill coefficient.
Results
CO 2 signaling of ROS-GC1 activity
It has been shown previously that bicarbonate supplied in a solution modulates ROS-GC1 catalytic activity both of native and recombinant forms [33, 34] . To determine whether CO 2 gas in the presence of carbonic anhydrase can mimic the bicarbonate effect, these two proteins (ROS-GC1 and carbonic anhydrase) were simultaneously expressed in COS cells which were then exposed to 15% CO 2 . In order to ensure that ROS-GC1 and carbonic anhydrase are indeed expressed in the same cell, their cDNAs were cloned into a vector (pBud CE 4.1) that is designed for independent expression in mammalian cells of two genes from a single plasmid. Indeed, every cell expressing ROS-GC1 expressed also carbonic anhydrase type II (CAII) (Fig. 2a) . The transfected cells were incubated without, or with, CO 2 and the amount of cyclic GMP formed was assessed as a measure of ROS-GC1's catalytic activity. In the absence of carbon dioxide, ROS-GC1 catalyzed the synthesis of ~ 200 ± 30 pmoles of cyclic GMP (mg prot) −1 regardless whether CAII was expressed or not ( Fig. 2b : panel "-CO 2 "). In the presence of CO 2 , there was 210 ± 35 pmoles of cyclic GMP (mg prot) −1 formed without CAII but 580 ± 90, with CAII ( Fig. 2b : panel "+CO 2 "). These results demonstrate that (1) carbonic anhydrase without CO 2 or CO 2 without carbonic anhydrase is without any effect on ROS-GC1 activity; (2) it is only when CO 2 is transformed into bicarbonate by the action of CAII that it stimulates ROS-GC1.
The carbonic anhydrase is widely present in living organisms starting from bacteria and algae finishing on the animal kingdom including humans but it is only, in at least some cone photoreceptors (mouse, human), that the expression of ROS-GC1 is accompanied by expression of CAII [35] and only one GCAP, GCAP1 [36] . Thus, it was tempting to simulate cone-native cellular conditions in heterologous system. Accordingly, wt-ROS-GC1, CAII, and GCAP1 were coexpressed in COS cells and the cells were incubated in the presence of gaseous CO 2 . Cyclic GMP formed was assayed as the measure of guanylate cyclase activity. The results are presented in Fig. 2c . The amount of cyclic GMP formed by wt-ROS-GC1 alone was approximately one-fourth of the cyclic GMP formed by ROS-GC1 in the presence of GCAP1 [compare: 250 pmol cGMP (mg prot) −1 vs. 950]. When coexpressed with GCAP1 and CAII, the wt-ROS-GC1 synthesized seven times higher amount of cyclic GMP than in its basal state and twofold higher than when co-expressed with GCAP1 alone under the same conditions. Thus, CO 2 in the presence of CAII mirrors the previously observed effect of bicarbonate [33] which potentiates the GCAP1 modulation of ROS-GC1 activity. The same will happen in these cone photoreceptors which possess CAII activity, and ROS-GC1 and GCAP1 as the only constituents of the ROS-GC/GCAP signaling system. congenital amaurosis (LCA1) and cone-rod degeneration (CORD6). Arginine at position 787, located within the third heptad of the signaling helix domain (SHD), is likely to be the most mutation-prone residue in ROS-GC1 as four single mutations and two complex mutations are known to affect it [37] . It therefore appears that the SHD of ROS-GC1 is the hot-spot for degenerative mutations. Here, we delve into the issue of how R 787 C mutation relates to the function of the third heptad of the signaling helix and through it of the ROS-GC1 enzyme and whether carbon dioxide ameliorates or worsens the functioning of cones affected by the mutations.
R
C and ΔH3 ROS-GC1 mutants localize to membranes and possess enzymatic activity
The biochemical effect of the R 787 mutation was explored using recombinant bovine ROS-GC1 and its two mutant forms, R 787 C and ΔH3. In ΔH3, amino acid residues 784-790 constituting the entire third heptad of the SHD, the location of the R 787 residue, were deleted. The first objective was to verify that the introduced mutations did not impair proper membrane targeting of the proteins. The wt-ROS-GC1 and its mutants were expressed in COS cells and Fig. 2 Carbon dioxide in the presence of CAII mimics the effect of bicarbonate on ROS-GC1 activity. COS cells were induced to express wt-ROS-GC1, co-express wt-ROS-GC1 and CAII, or co-express wt-ROS-GC1 (or ROS-GC1-CAII) with GCAP1. The ROS-GC1-CAII construct in pBud vector is described in "Materials and methods" section. a COS cells transfected with ROS-GC1-CAII construct. Every cell expressing ROS-GC1 expresses also CAII as verified by immunocytochemistry using anti-ROS-GC1 and anti-CAII antibodies. The cells were viewed using an inverted Olympus IX81 microscope/FV1000 Spectral laser confocal system. b COS cells expressing ROS-GC1 or ROS-GC1 and CAII were incubated in the absence or presence of 15% CO 2 at 37 °C. c COS cells expressing ROS-GC1, ROS-GC1, and CAII or co-expressing GCAP1 with ROS-GC1 or ROS-GC1 and CAII were incubated in the presence of 15% CO 2 at 37 °C. After the incubation, the cells were scraped from the culture dishes, homogenized by passing through 30G needle, centrifuged and cyclic GMP was deter- analyzed by immunostaining with anti-ROS-GC1 antibody (Fig. 3a) . In all three cases, immunoreactive bodies were found predominantly in the membranes of the endoplasmic reticulum and to a lower extent in the plasma membrane and importantly, the levels of expression of these three proteins were the same. This pattern of expression in a heterologous system agrees with previous observations [18, 38] . Thus, the mutants, similar to their parental ROS-GC1, remain membrane proteins.
To assess enzymatic functionality, the wt-ROS-GC1, the R 787 C and ΔH3 mutants were expressed in COS cells and their guanylate cyclase activities were determined in C and ΔH3 mutants localize to membranes and are enzymatically functional. COS cells were transfected with cDNA of wt-ROS-GC1 or its R 787 C and ΔH3 mutants. a 72 h after transfection, the cells were fixed and incubated with anti-ROS-GC1 antibody followed by incubation with secondary antibodies conjugated with DyLight 647 (excitation at 650 nm). The cells were viewed using an inverted Olympus IX81 microscope/ FV1000 Spectral laser confocal system. In all three cases, the immunoreactive bodies were found predominantly in the membranes of the endoplasmic reticulum and to a lower extent in the plasma membrane. The immunostaining also shows that the levels of expression of these three proteins were the same. the cells particulate fractions (Fig. 3b) . The activity of the wt-ROS-GC1 was 100 ± 21 pmol cGMP min (mg protein) −1 whereas the activities of the mutants were 39 ± 11 and 36 ± 6 for the R 787 C and ΔH3, respectively. When the mutants were analyzed for the dependences of their activities on GTP concentration, they showed identical relations between the activity and the substrate concentration as well as between the substrate concentration and the reaction rate (Fig. 3c) . The GTP concentration at which the activities of the wt-ROS-GC1 and of both mutants were equal one-half of the maximal activity (EC 50 Reduced GCAP1-modulated Ca 2+ signaling of ROS-GC1 mutants GCAP1 binds ROS-GC1 molecule at aa L 503 -I 522 region within the JMD [40] . To determine if the mutations within SHD interfere with GCAP1 binding, the interaction was monitored in heterologous system by immunofluorescence. GCAP1 tagged with green fluorescent protein (GFP) was expressed alone or together with wt-ROS-GC1 or its R 787 C mutant. When expressed alone, GCAP1-GFP was evenly scattered in all cellular compartments including the nucleus (Fig. 4a) . This pattern of heterologous expression of GCAP1 was compatible with the earlier observations [18, 41] . When co-expressed with ROS-GC1 or its mutant the GCAP1-linked GFP fluorescence migrated to the membranes and followed the pattern of ROS-GC1 immunofluorescence ( Fig. 4b and d for ROS-GC1 and Fig. 4e , g for the R 787 C mutant). Similar results were obtained for the ΔH3 mutant (not shown). These results demonstrate that qualitatively the interaction between GCAP1 and any of the mutants does not differ from that between GCAP1 and wt-ROS-GC1.
Membranes of COS cell expressing the mutants or the wt-ROS-GC1 were further analyzed for GCAP1-dependent activation. They were exposed to increasing concentrations of GCAP1. To ensure that the GCAP1 is Ca 2+ -free, the standard reaction mixture was supplemented with EGTA to C mutant. COS cells were transfected with GCAP1-GFP cDNA or were co-transfected with cDNA of GCAP1-GFP and ROS-GC1 or its R 787 C mutant. 72 h after transfection the cells were fixed and incubated with anti-ROS-GC1 antibody followed by secondary antibody as described in "Materials and methods." Expression of GFP-GCAP1 was traced by green fluorescence. The cells were viewed using an inverted Olympus IX81 microscope/FV1000 Spectral laser confocal system. a GCAP1-GFP expressed alone; b GCAP1-GFP co-expressed with ROS-GC1; c ROS-GC1 co-expressed with GCAP1-GFP; d merge of (b) and (c); e GCAP1-GFP co-expressed with R 787 C mutant; f R 787 C mutant coexpressed with GCAP-GFP; g merge of (e) and (f) the final concentration of 1 mM resulting in ~ 10 nM free Ca 2+ . Ca 2+ -free GCAP1 stimulated the activity of the wild type and the mutant cyclases in a dose-dependent fashion (Fig. 5a) . The half-maximal stimulation occurred at ~ 1 µM GCAP1 (denoted as EC 50 ) for the mutants and the wild-type cyclase and the Hill's coefficient values were also very close to each other, being 1.93 ± 0.3, 2.10 ± 0.1, and 2.16 ± 0.1 for wt-ROS-GC1, R 787 C, and ΔH3 mutants, respectively. The V max achieved by wt-ROS-GC1 was 490 pmol cyclic GMP min −1 (mg protein) −1 , by the R 787 C mutant, 340 and by the ΔH3 mutant it was 320. Thus the mutants, although being activated by GCAP1, did not reach the same maximal enzymatic velocity as the wt-ROS-GC1 did. Another approach to analyze the response of a protein to any ligand is to calculate its x-fold stimulation above the basal activity, triggered by the ligand. When the mutants were analyzed this way a different picture emerged. They were twice as responsive to GCAP1 as the wt-ROS-GC1 was (Fig. 5b : compare 9-10 fold stimulation for the mutants and fourfold stimulation for the wt-ROS-GC1). Thus, the mutants while exhibiting overall lower activity were hyper-responsive to GCAP1.
The dependency of ROS-GCs catalytic activity on [Ca 2+ ] i via GCAPs is the hallmark feature of the ROS-GC/GCAP signaling system in phototransduction. To test whether the mutants adhere to this trend, the GCAP1-dependent activities of each mutant and of the wt-ROS-GC1 were determined at different free Ca 2+ concentrations ranging from 10 nM to 10 µM. Typical profiles are shown in Fig. 6 . The Ca 2+ concentration at which the activity of each cyclase is half-maximal was approximated graphically from these plots and is denoted as IC 50 . For easier comparison of the IC 50 values, the activities were normalized; the cyclases activities at 10 nM Ca 2+ were taken as maxima and at 10 µM as minima. Increasing concentrations of free Ca 2+ resulted in dose-dependent lowering of GCAP1-stimulated activity of all the cyclases, the wt-ROS-GC1 and the mutants, but with evident differences. While the IC 50 value for the wt-ROS-GC1 was ~ 370 nM, free Ca 2+ , it was shifted to almost twofold higher free Ca 2+ concentrations, ~ 650 nM for the R 787 C and ΔH3 mutants (Fig. 6 ). These results demonstrate that the . The values presented are representative of two experiments done in triplicate R 787 C and ΔH3 mutations in ROS-GC1 result in cyclases that are more resistant to Ca 2+ -dependent inhibition.
Restorative effect of bicarbonate on mutant ROS-GC1 activity
Contrary to GCAPs, bicarbonate stimulates ROS-GC1 activity in a Ca 2+ -independent mechanism. As a first step in examining the effect of the R 787 C and ΔH3 mutations on bicarbonate signaling of ROS-GC1 activity, the mutants were tested whether they respond to bicarbonate. Membranes of COS cells expressing wt-ROS-GC1 or the mutants were exposed to 50 mM bicarbonate and their activities were determined. They were 340, 134, and 148 pmol cyclicGMP min −1 (mg prot) −1 for the wt-ROS-GC1, R 787 C, and ΔH3 mutants, respectively. Thus, the mutants, although not attaining the same as wt-ROS-GC1 V max , were stimulated in their activities by bicarbonate ~ fourfold above the basal values, identically as the wt-ROS-GC1 was. Hence, the mutations did not affect the cyclases' pattern of response to bicarbonate. When the membranes were challenged with rising concentrations of bicarbonate, both mutants responded with a dose-dependent increase in activity (Fig. 7) . At ~ 80 mM bicarbonate both mutants achieved their V max 's that were fivefold above the basal velocities; however, as the consequence of the lowered basal activity, the absolute values of the maximal activities were below the level reached by wt-ROS-GC1. The Hill coefficients were 2.46 for the R 787 C mutant and 2.30 for the ΔH3; the values close to the 2.6 value observed for the wt-ROS-GC1 in these experiments as well as in previously reported [33] . These results reveal that the R 787 C and ΔH3 mutations are neutral with respect to bicarbonate signaling of ROS-GC1 activity; they neither enhance nor hinder the signaling. GCAP1 and bicarbonate together enhance each other's effect on ROS-GC1 activity and operate synergistically [30, 33] . It was, therefore, imperative to test whether the same remained true for the R 787 C and ΔH3 mutants. To test this, COS cell membranes expressing individually both mutants or wt-ROS-GC1 as control were reconstituted with increasing concentrations of GCAP1 at 10 nM Ca 2+ in the presence and absence of 50 mM bicarbonate and the amount of cyclic GMP was assayed as a measure of the guanylate cyclase activity (Fig. 8) . As expected, 50 mM bicarbonate enhanced GCAP1 mediated stimulation of wt-ROS-GC1, lowered the EC 50 value for GCAP1 to ~ 0.6 µM and raised V max to ~ 1000 pmol cyclic GMP min −1 (mg prot) −1 . It also increased the guanylate cyclase activity over the GCAP1 concentrations tested. Surprisingly, the mutants achieved almost the same maximal velocity as wt-ROS-GC1 under the same experimental conditions, ~ 1000 pmol cyclicGMP min −1 (mg prot) −1 . These results show that bicarbonate further boosts the hyper-responsiveness of the mutants R 787 C and ΔH3 mutants to GCAP1.
CO 2 signaling of the R
C mutant
The results presented above show that the characteristic for CORD6 ROS-GC1 mutation, R 787 C and deletion of the signaling helix domain third heptad where this mutation is located, affect similarly ROS-GC1 activity and its Ca 2+ -dependent and -independent modulations. Having these pieces of information gathered, an attempt was made to repeat the experiment with CO 2 and wt-ROS-GC1 but using the R 787 C mutant instead. The mutant was expressed in COS cells with CAII and/or GCAP1 and the cells were exposed to 15% CO 2 . Cyclic GMP formed was determined as a measure of the mutant's guanylate cyclase activity. The results are shown in Fig. 9 . In its basal, unstimulated state the R 787 C mutant synthesized 117 pmol cyclic GMP (mg prot) −1 , an amount slightly lower than one-half of the amount of cyclic GMP synthesized by wt-ROS-GC1 [compare Fig. 2 : 270 pmol cGMP (mg prot) −1 ] . When coexpressed with GCAP1, the mutant formed approximately 6-times more cyclic GMP, 650 ± 100 pmol cGMP (mg prot) −1 , but it was still less than wt-ROS-GC1 did [compare Fig. 2 : 960 ± 40 pmol cGMP (mg prot) −1 ]. Finally, when coexpressed with GCAP1 and CAII the amount of cyclic GMP synthesized by the mutant rose up to 1475 ± 80 pmol cGMP (mg prot) −1 , an amount almost 13-times over its basal value and 2-times over its GCAP1 stimulated level. Thus, CO 2 in the presence of CAII mirrors the effect of bicarbonate by potentiating the GCAP1 influence on ROS-GC1 activity. Although the amount of cyclic GMP formed by the mutant did not reach the amount formed by the native cyclase [1660 ± 160 pmol cGMP (mg prot) −1 ] as it was in the reconstitution experiment with COS cells membranes, exogenous GCAP1, and solution of sodium bicarbonate (Fig. 7) still, the numbers are close enough to allow a conclusion that CO 2 through bicarbonate formed in the presence of CAII will increase the synthesis of cyclic GMP in the CORD6-affected cone photoreceptors to the level nearing this in normal ones.
Discussion
There are several highly innovative aspects of the present investigation.
Gaseous CO 2 signal transduction pathway
Besides the mouse olfactory neurons [42] , the gaseous CO 2 -modulated membrane guanylate cyclase transduction system has not been reported in any vertebrate sensory neurons. Even more, the mouse gene, ONE-GC (alternatively named GC-D) [43, 44] is a pseudogene in humans [45, 46] . It has thus been concluded that CO 2 is odorless for humans [47] and the CO 2 -modulated membrane guanylate cyclase transduction system is in the exclusive domain of the mouse (rodent) olfactory system.
The present report demonstrates that photoreceptor ROS-GC1 is modulated by CO 2 . This conclusion is arrived at through experimentation using a recombinant wt-ROS-GC1 reconstituted in a heterologous system mimicking the cellular conditions of the native cones. Co-expressed with CAII inCOS cells, it is stimulated more than 2.5-fold by gaseous CO 2 (Fig. 2b) . In the absence of CO 2 , CAII is ineffective in stimulating ROS-GC1; like-wise, CO 2 in the absence of CAII is without any effect. Because functionally CAII catalyzes generation of bicarbonate from CO 2 , it is inferred that CO 2 signals via bicarbonate stimulation of ROS-GC1 catalytic activity.
Bicarbonate mediates CO 2 -modulated pathway
Bicarbonate is directly sensed by the photoreceptor ROS-GC1 [30, 33] . It stimulates its catalytic activity regardless of [Ca 2+ ] i , the stimulation does not require the GCAPs domains and, importantly, the two pathways, bicarbonate and GCAPs, originate at the opposite ends of ROS-GC1 [33] , and at the physiological level CO 2 is functional in the GCAP1-and GCAP2-double knockout mice [30] . Thus, these pathways at the biochemical and physiological levels are divergent. Together with the evidence that CO 2 stimulates the catalytic activity of ROS-GC1, and physiologically through bicarbonate enhances the circulating current, decreases sensitivity to the flashes and accelerates flash response kinetics in the salamander red-sensitive cones [33, 34] , it is concluded that CO 2 modulates cone phototransduction via its mediator bicarbonate. This conclusion is in accordance with the evidence that human red-and green-sensitive cones express the CAII in their outer segments [35] .
Proposed mechanism (Fig. 10) Incorporating these facts, we propose a CO 2 -modulated signal transduction mechanism for the cone phototransduction C mutant with GCAP1 and CAII. The cells were incubated at 37 °C in the presence of 15% CO 2 . After the incubation, they were scraped from the culture dishes, homogenized by passing through 30G needle, centrifuged and cyclic GMP was determined by RIA in the supernatant. The experiment was done in triplicate 1 3 pathway. Generated in the cone outer segment or diffused in the plasma membrane, carbon dioxide is sensed by CAII which catalyzes its reaction with water molecule leading to the formation of H + and HCO 3 − . The produced bicarbonate directly targets the catalytic domain (CCD) of ROS-GC1 and activates it to increased synthesis of cyclicGMP which is a two-step process. In the first step, the circlet-like structure formed by two antiparallel oriented monomers of CCD [39] partially closes to attach the substrate Mg 2+ -GTP, a requirement for the basic catalysis to occur. In the subsequent step, upon receiving the ligand (bicarbonate)-generated signal the circlet tightens, and creates cyclic GMP at the cyclase's full capacity (exemplified by Fig. 3 in ref. [39] ).
GCAP1 signaling pathway
Presently, this pathway is misdirected by some groups. It requires critical evaluation to understand its true biochemistry and physiology.
More than two-decades of structural analyses of the recombinant ROS-GC1 [4] (reviewed in ref. [6] , Fig. 4 ) have revealed the boundaries and functions of its modular blocks. Two Ca 2+ -modulated GCAPs, 1 and 2, from their independent targeted domains located, respectively, in juxtamembrane domain (JMD) and C-terminal extension (CTE) of ROS-GC1, generate two non-overlapping signaling pathways [5, 30, 39, 40, [48] [49] [50] . Both signals are translated by the catalytic domain (CCD) into the enhanced production of cyclic GMP, which, in turn, serves as the second messenger of phototransduction. Before entering CCD, the GCAP1 signal passes sequentially through the 657 WTAPELL 663 and of L 770 -P 807 SHD micro-domains (Fig. 1 ). There is a critical functional interplay between these two modular domains. Remarkably, the WTAPELL and SHD modules control almost 90% of the GCAP1's regulatory activity [18, 31] . The 657 W residue in the WTAPELL is the primary factor, controlling about 73% of the module's total Ca 2+ -modulated GCAP1 signaling activity. This conclusion has a critical bearing on understanding the pathology of the LCA1 and CORD6 diseases. These diseases are consequences of the ROS-GC1-specific mutations, all residing in the Ca 2+ -modulated GCAP1-signaling pathway, LCA1: F 514 S [20, 51] , recently described A 659 V [52] and CORD6: R 787 C [23] .
Signaling helix domain (SHD)
The function-based SHD term was coined for proteins containing a five-heptad conserved structural motif between two signaling domains [53] . ROS-GC1's five-heptad-SHD module, amino acid residues L 770 -P 807 [31] meets this criterion and has 50% structural conservation, including all the most preserved residues, with the signaling helix sequence logo [53] . This domain is one of the central points in the present investigation.
In ROS-GC1, SHD module is wedged between the kinase homology domains (KHD) and the CCD (Fig. 1) . Prior to the use of SHD terminology [53] , a corresponding, ~ 50-amino acid linker region of ANF-RGC (atrial natriuretic factor receptor guanylate cyclase) was named dimerization domain (DD) [54, 55] . It was argued that DD functioned to assemble two monomeric subunits of ANF-RGC into a homodimer that represents the functional cyclase. The prediction was that the DD structure represents an amphipathic helix in ] i some cyclic GMP is hydrolyzed to 5′-GMP the ANF-RGC monomer and a coiled-coil structure in the homodimer. This ANF-RGC-based concept was extended to ROS-GC1 [56, 57] for which it was proposed that the coiled-coil-DD structural unit was the critical component for ROS-GC's catalytic activity. This idea is the driving force for some groups to define and link the GCAPs-modulated Ca 2+ signal transduction mechanisms with phototransduction, and, in turn, to explain the CORD's retinal dystrophies [56] [57] [58] [59] .
Multiple studies, including this one, do not support this idea. The so-called "DD" linker region is neither a dimer forming element nor does it assume a typical coiled-coil structure [38, 39, [60] [61] [62] [63] . The CCD module, ranging in existence from the bacterium Cya2 [64] and eukaryotic green algae Cyg12 [65] guanylate cyclases to the mammalian ROS-GC1 [39, 63] , is intrinsically dimeric and catalytically active; it does not require "DD" linker region for its basal catalytic activity.
The R 787 residue of heptad 3 is an amplifier of the SHD's transmission activity
Basal ROS-GC1 catalytic activity
The prediction that SHD module, indeed, constitutes a transduction switch has been supported for its role in suppressing the catalytic activities of the guanylate cyclases-STa-RGC [62] and ROS-GC1 [31, 38] . It has thus been concluded that function of the effector ligand is to overcome the suppression and enhance the catalytic activity of CCD. Yet, puzzlingly, the R 787 C mutation linked with CORD6 alone causes a significant decrease (~ 60%) in the catalytic activity (Fig. 3b) , a phenomenon also observed earlier [26, 27, 56 ], yet not commented upon.
The present investigation carried out with the ΔH3 ROS-GC1 mutant further supports the above conclusion by demonstrating that the mutant also lacks most of its catalytic activity (Fig. 3c) .
Ca
2+ -dynamic changes
Under physiological conditions in the photoreceptor outer segments, ROS-GC1 activity is determined by dynamic changes in cytoplasmic Ca 2+ concentrations through GCAP1. The activity is high at low [Ca 2+ ] i and decreases as the Ca 2+ concentration increases resulting in light-and dark-specific cyclic GMP/Ca 2+ homeostasis. Do the R 787 C mutation and/or deletion of the third heptad affect this paradigm? The answer is "yes." At low nanomolar Ca 2+ , the activities of both mutants are controlled by GCAP1 in a dose-dependent fashion (Fig. 5) ; however, their catalytic efficiencies are lower than that of the wt-ROS-GC1 resulting in reduced cyclic GMP synthesis. With increasing Ca 2+ concentrations, the GCAP1-dependent activity of the R 787 C and ΔH3 mutants decrease but the half-maximal inhibition occurs at Ca 2+ concentration almost two times higher than that for wt-ROS-GC1 (Fig. 6: (Fig. 7) . Hence the mutations do not affect the catalytic activities of the guanylate cyclase in response to bicarbonate. Keeping in mind that the R 787 C and ΔH3 mutations lower basal ROS-GC1 activity (Fig. 3) , and that GCAP1 stimulation is not sufficient to overcome this lowering (Fig. 5a) , the intriguing finding is that when bicarbonate is present together with GCAP1, it brings the activities of both mutants to the level of wt-ROS-GC1 (Fig. 8) . Similar "rescue" effect occurs when R 787 C mutant expressed in COS cells together with CAII and GCAP1 is exposed to CO 2 (Fig. 9) ; the specific activity achieved by the mutant is comparable to that achieved by the wt-ROS-GC1 (compare Figs. 2, 9 ). Thus, bicarbonate being a mediator of CO 2 enhances the amplifying ability of R 787 and H3 in ligand (GCAP1)-signaling of ROS-GC1 activity.
Heptad 3 and the pathogenesis of CORD6
Although the primary consequence of R 787 C and ΔH3 mutations is low basal catalytic activity in ROS-GC1 and its failure to be fully activated by GCAP1 at low [Ca 2+ ], the CORD6 caused by the R 787 C mutation seems unlikely to be instigated exclusively by low cyclic GMP synthesis. Instead, the additional reason of the disease arises from the secondary cause. It is the altered Ca 2+ sensitivity of the ROS-GC1/ GCAP1 complex that maintains ROS-GC1 in an activated state even in darkness causing non-physiological elevation of intracellular cyclic GMP. Raised levels of cyclic GMP are toxic in part because they allow lethal levels of Ca 2+ to enter photoreceptor cells [66] . Another consequence of elevated intracellular levels of cyclicGMP is an exuberant activity of cyclic GMP-dependent protein kinase (PKG), what is also detrimental [67] .
Global function of heptad 3 and R 787 analogous conserved residue
With the presented facts that H3 of SHD and its node residue R 787 are critical in tuning total modular activity in the ROS-GC, and that this residue is the central part of the "ERT" conserved signature motif in the membrane guanylate cyclase family [53] , the question was raised does R 787 have a global function? Would its mutation in other guanylate cyclases cause a loss of function and lead to a serious abnormality?
The answer is yes, based on the analysis of two different subtypes of the guanylate cyclase family and both belonging to the hormone receptor subfamily: atrial natriuretic factor (ANF) receptor guanylate cyclase (ANF-RGC or NPR1) and C-type natriuretic peptide (CNP) receptor guanylate cyclase (CNP-RGC or NPR2).
ANF-RGC
By sensing ANF hormone pulsated through heart beats [68] and [Ca 2+ ] levels modulated by neurocalcinδ, ANF-RGC [69, 70] is the pivotal molecule that controls blood pressure and combats hypertension (reviewed in: ref. [6] ). Thus, we reasoned that ANF-RGC's H3 in SHD module and specifically its R 802 residue (corresponding to R 787 in ROS-GC1) should also be critical in controlling catalytic activity of the guanylate cyclase. And, indeed, it is. Deletion of H3, or mutation R 802 C, disables most of ANF-RGC's basic catalytic activity with the concomitant blunted response to ANF/ATP in the ligand-dependent activation. (Supplemental Information: Fig. S1 ).
CNP-RGC
To broaden this theme, we surveyed the literature on CNP-RGC. Here, the corresponding to ROS-GC1 R 787 residue is R 819 . The R 819 C mutation in human causes acromesomelic dysplasia, characterized by severe dwarfism [71] . Because dwarfism is also observed in the CNP-RGC-or CNP-gene knockout mice with disability to produce cyclic GMP [72, 73] , we conclude that analogous to ROS-GC1 H3 and its R 787 conserved residue, the R 819 in CNP-RGC is also critical for controlling physiology and biochemistry of other members of the guanylate cyclase family. Hence, the residue has a critical guanylate cyclase-specific global functional role in which it disables the catalytic activity of the guanylate cyclase.
Additional possible consequences of R
C mutation
Expression of ROS-GC1 is not restricted to the retina. Outside the retina ROS-GC1 and GCAP1 signal transduction system is expressed in mitral cells of the olfactory bulb [74] and in a subpopulation of pinealocytes [75] . Any genetic mutation in ROS-GC1 will not be limited to retinal expression of ROS-GC1 but will occur in every ROS-GC1 molecule throughout the body. It is therefore an imperative that from a clinical point of view, all individuals afflicted with CORD6 in addition to monitoring their vision are also tested for abnormalities in their sense of smell as well as in sleep and wakefulness cycles. When traveling, these individuals should be advised on the possibility of enhanced effects of jet lag, especially in eastward travel, because of disturbance in melatonin secretion by pineal gland.
The presented results, however, offer the potential that the severity of these abnormalities may be, at least to some extent, ameliorated by accessibility of CO 2 /carbonic anhydrase/bicarbonate. As a powerful modulator of ROS-GC1, bicarbonate is likely to influence the penetrance and severity of diseases caused by dysregulation of cyclic GMP synthesis. If CO 2 /bicarbonate were to reach sufficient levels it might support adequate cyclic GMP synthesis by ROS-GC1 thus repairing abnormalities resulting from reduced cellular cyclic GMP levels. On the other hand, inhibition of bicarbonate production by carbonic anhydrase inhibitors may be therapeutic in attenuating disease processes caused by elevated cyclic GMP levels.
Conclusions
In summary, this study is the beginning of biochemical characterization of a novel gaseous CO 2 -modulated ROS-GC signal transduction pathway in the photoreceptor sensory neurons. Via its outstanding mode of regulation, the pathway applies outside impact on the conventional conelinked systems. To date, this pathway has been denied to exist in humans and other vertebrates; only exception is in the rodents, yet the rodent membrane guanylate cyclase is represented by a pseudogene in humans. The human and the conserved ROS-GC1 gene in vertebrates exists in other sensory neurons linked with olfaction, pinealocytes, and gustatory epithelium; in all the neurons, the encoded guanylate cyclase is Ca 2+ -modulated. Do these sensory neurons, like photoreceptors, embody gaseous CO 2 -modulated signaling pathway and, thus, able to sense CO 2 ? This study offers this possibility and opens these fields of investigation.
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